Application Nr Approved Date Route Status External Links
NDA050790 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 In Dications And Usage Restasis ® Ophthalmic Emulsion Is Indicated To Increase Tear Production In Patients Whose Tear Production Is Presumed To Be Suppressed Due To Ocular Inflammation Associated With Keratoconjunctivitis Sicca. Increased Tear Production Was Not Seen In Patients Currently Taking Topical Anti-Inflammatory Drugs Or Using Punctal Plugs. Restasis ® Is A Calcineurin Inhibitor Immunosuppressant Indicated To Increase Tear Production In Patients Whose Tear Production Is Presumed To Be Suppressed Due To Ocular Inflammation Associated With Keratoconjunctivitis Sicca. Increased Tear Production Was Not Seen In Patients Currently Taking Topical Anti-Inflammatory Drugs Or Using Punctal Plugs. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cyclosporine

Comments